Command Palette

Search for a command to run...

BIOCON

394.65-4.1 (-1.03%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Significant rise in net sales to ₹4417 crore in Q1 202503, up from ₹3821.4 crore last quarter.
  • Operating margin improved substantially to 9.72% this quarter, reflecting enhanced operational efficiency.
  • Net profit surged to ₹459.4 crore, showcasing a strong recovery compared to previous quarters.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25
Revenue
3,422.603,462.303,953.703,917.103,432.903,590.403,821.404,417
Expenses
3,299.203,357.703,708.103,635.203,453.903,550.503,718.403,987.50
Operating Profit
123.40104.60245.60281.90-2139.90103429.50
Other Income
93.50157.90565.5048.601,134.5032.5034.8036.90
Interest
233247.70266.70227236225.60223.40212.40
Depreciation
358389.30414.50407405.40419.90425.40436.30
Profit Before Tax
183.70214.30808.203191,145.5098.40155.90486.80
Tax
34.8041.6054.9096.10283.7071.3074.8027.40
Net Profit
148.90172.70753.30222.90861.8027.1081.10459.40
EPS in Rs
0.851.055.521.135.51-0.130.212.88